Objectives: Allergen-specific immunotherapy (AIT) is an effective treatment for allergic disease but requires long treatment duration and premature cessation is of significant concern. Drivers of premature cessation remain poorly understood and no predictive models currently exist. We hypothesized that a novel patient journey map and de novo real-time patient electronic health status instruments (eHSIs) could effectively capture patient perceived cost, commitment, and treatment benefit to identify individual patients at risk for premature AIT cessation.
View Article and Find Full Text PDFBackground: Clozapine is a first-line therapy and the only FDA-approved drug for patients with treatment-resistant schizophrenia (TRS). However, frequent measurement of absolute neutrophil count (ANC) is required to monitor for potential adverse severe neutropenia from clozapine therapy. We evaluated 3 point-of-care (POC) instruments that perform the complete blood count (CBC) with differential to assess their analytical performance and potential to meet the clinical need for clozapine therapy management.
View Article and Find Full Text PDFLaryngoscope Investig Otolaryngol
June 2021
Objective: A consolidated state-of-the-art review of U.S. healthcare reform efforts that documents the evolution towards value-based healthcare (VBH) is lacking in peer-review literature.
View Article and Find Full Text PDFObjectives: Investigate the current trends in otolaryngic allergy (OA).
Study Design: Cross-sectional survey.
Methods: Survey of active AAOA membership.
Objectives/hypothesis: To investigate contemporary issues facing practicing otolaryngologists including workforce dynamics, ancillary service modeling, otolaryngic allergy integration, ambulatory surgery center utilization, and relevant certificate of need legislation.
Study Design: A cross-sectional survey analysis of academic and private practicing otolaryngologists in North and South Carolina in 2016.
Methods: A cross-sectional survey was e-mailed to 510 practicing otolaryngologists in North and South Carolina.
Background: The symptoms and treatments for nasal obstruction are numerous and common. Yet, a consensus on a surgical approach or, even more importantly, how to define the success of any approach is lacking in the literature. A disease-specific outcomes instrument recently developed by the American Academy of Otolaryngology, known as the Nasal Obstruction Symptom Evaluation (NOSE) scale, has allowed for a validated, uniform method to compare different treatments for nasal obstruction.
View Article and Find Full Text PDFArch Otolaryngol Head Neck Surg
January 2000
Objective: To assess the baseline global health status and quality of life (QOL) in children with tonsil and adenoid disease.
Design: Cross-sectional multicenter survey series.
Settings: A tertiary academic pediatric specialty hospital and a tertiary academic hospital in 2 different cities.
Otolaryngol Head Neck Surg
April 1999
Otolaryngol Head Neck Surg
October 1997
Practice guidelines (PGs) are becoming increasingly important in modern medicine. To study the effects of a PG, we performed a pilot study at a large, urban, public teaching hospital according to a prospective, observational research design with both concurrent and historic controls. Specifically, we studied the effects of a multidisciplinary PG for pediatric outpatient tonsillectomy and adenoidectomy on the process of health-care delivery.
View Article and Find Full Text PDFObjective: To identify a consensus on the postoperative barorestrictions after stapes surgery and to examine the clinical barotrauma experience within this patient population encountered by the surveyed physicians.
Data Source: A 34-item survey was developed, allowing for detailed analysis of physician demographic data, practice characteristics, surgical experience, and clinical experience with barotrauma after stapes surgery. The postoperative restrictions addressed by the survey included those for air travel, snorkeling, and scuba diving.
Rhinocerebral mucormycosis is a well-described fulminant fungal infection that typically presents acutely in patients with diabetic ketoacidosis or immunosuppression. Chronic presentations of rhinocerebral mucormycosis have also been described. In the chronic infection, the disease course is indolent and slowly progressive, often occurring over weeks to months.
View Article and Find Full Text PDF